COMPANY PROFILE

Bodyport

Explore full profile

One step The whole picture Bodyport is changing our approach to healthcare by moving it into the home

San Francisco, United StatesFounded 2015Health Tech & Medtech

Valuation $50–100M Last recorded · 2020

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Bodyport

Bodyport is a digital therapeutics company focused on empowering individuals to manage complex chronic conditions, particularly heart failure. The company integrates a sophisticated biomarker platform into user-friendly, at-home devices that noninvasively measure a wide range of hemodynamic biomarkers. This allows patients and their care teams to better predict, understand, and intervene in changes to heart health, ultimately reducing hospital visits and improving overall health outcomes. Bodyport serves patients with chronic conditions and operates in the healthcare market. The business model revolves around providing actionable health insights through its proprietary platform, generating revenue from device sales and potentially subscription-based services for ongoing health monitoring.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2015
Headquarters: San Francisco, United States
Employees: 16
Open positions: None listed
Dealroom signal: 68.1/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Chronic Disease, Wearable, Hard Tech, YC S15, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing, SaaS
Client focus: b2b, b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Aug 2020	$11M	$45M	Kapor Capital · Initialized Capital · Boehringer Ingelheim Venture Fund · Playground Global	—
SEED✓Equity / VC	Feb 2018	$2M	$8M	Initialized Capital	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Bodyport website traffic

Latest recorded traffic for Bodyport is 190 monthly website visits, down 88.1% over the last three months. Bodyport's team grew 0% over the past year.

Latest monthly visits190 3-month web change-88.1% 1-year team growth0%

Monthly website visitsOct 2017–Jun 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SISiDLYManufacturer of telemedicine bands based on a proprietary medical device	Warsaw, Poland	Operational	57	$1.6M	$2.3M
RHRecovery Force HealthRF Health brings innovative medical devices and patented technology to hospital patients and clinicians	Fishers, United States	Operational
STSTILDeveloping a new method to suppress tremor, based on the concept on noise-cancelling	Delft, Netherlands	Operational
LILiveMetricLiveMetric is transforming the care and condition-management of hypertension and cardiovascular diseases	New York City, United States	Operational
NHNoctrix HealthEarly-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness	Pleasanton, United States	Acquired
TOToSenseToSense is focused on rapidly bringing devices to the market that address real-world medical issues	San Diego, United States	Acquired
LMLymphatica MedtechA minimally invasive implant and a discrete wearable device designed to re-establish the lymphatic circulation	Lausanne, Switzerland	Operational
MEMedicsenNeedle-free drug delivery platform based on sonophoresis (ultrasounds) to replace needles and cannulas in the transdermal delivery of large molecules	Madrid, Spain	Operational